Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children
- Supplementary File 1:
PDF-Document (PDF, 327 KiB)
Dispinseri, S.; Cavarelli, M.; Tolazzi, M.; Plebani, A.M.; Jansson, M.; Scarlatti, G. Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children. Vaccines 2021, 9, 260. https://doi.org/10.3390/vaccines9030260
Dispinseri S, Cavarelli M, Tolazzi M, Plebani AM, Jansson M, Scarlatti G. Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children. Vaccines. 2021; 9(3):260. https://doi.org/10.3390/vaccines9030260
Chicago/Turabian StyleDispinseri, Stefania, Mariangela Cavarelli, Monica Tolazzi, Anna Maria Plebani, Marianne Jansson, and Gabriella Scarlatti. 2021. "Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children" Vaccines 9, no. 3: 260. https://doi.org/10.3390/vaccines9030260